Read this week’s analysis and observations on public opinion trends from pollster and social scientist President of Ipsos Public Affairs, US, Cliff Young. Each week Cliff will look underneath topline trends to lay out the forces that are really shaping our society and our future.
April 9: Our National Dissonance
April 2: Advancing A Post-COVID Agenda
February 26: Cliff’s Take: Getting Our Bearings
February 5: Cliff’s Take: Americans In Wait And See Mode
January 29: Cliff’s Take: Rage Against The Machine?
December 31: Cliff’s Take: Farewell to 2020
December 18: Cliff’s Take: American Disenchantment
November 25: Our First – And Hopefully Last – COVID Thanksgiving
November 13: Cliff’s Take: Nation Begins To Move Forward
October 30: Cliff’s Take: Buckle Up
October 16: Cliff’s Take: Down to the Wire
October 9: Cliff’s Take: Coronavirus as King Maker
September 25: Cliff’s Take: Contradictory Signals
September 11: Cliff’s Take: Coronavirus A Dividing Line
August 14: Cliff’s Take: Beware of Horse Race Polls
August 7: Cliff’s Take: Willing Away The Virus
July 10: Cliff’s Take: The Great Unraveling
February 14: Cliff's Take: Biden's Electability Lead Fizzles
December 20: Cliff's Take: Cognitive Surplus
November 26: Cliff's Take: Where the Rubber Meets the Road
November 14: Cliff's Take: Is Mayor Pete Trending?
November 6: Cliff's Take: Is Trump Distracted?
October 30: Cliff's Take: A Closer Look at Electability
October 22: Cliff's Take: Keep Your Eyes on Approval Numbers
October 15: A Crisis of Confidence in Our Electoral System
October 8: Country Music and Tribalism
October 1: Impeachment in the Global Context
September 24: The Forces that Produced Our Uncertain World Persist
September 16: Tattoos and Identity
September 9: No trees, just forest
Be sure to join the mailing list in order to receive each edition in the series directly to your emailbox. Or return to our website regularly for new content.
[WEBINAR] Physician-Administered Therapies: Access Strategies & Insights
Join Ipsos for a complimentary webinar as we explore the expected evolution of the access and reimbursement environment for physician-administered therapies, and outline what it means for you as you prepare to launch physician-administered therapies.